Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it has significantly enhanced its drug discovery service capabilities by strengthening its commercial and chemistry teams to deliver an even more comprehensive range of services to the global life science research community.
Jason Mundin has joined the board as Commercial Director to drive the growth of Ubiquigent along with Jason Brown, founder and now Scientific Director and Mark Treherne, Executive Chairman. Laurence Ede also joins as a non-executive director to support the development of the company. John Harris has joined the Scientific Advisory Board to lead Ubiquigent’s new chemistry strategy. Ubiquigent also announced the...
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the use of their NanoTracker™ 2 optical tweezers system which is being used to study the physical and chemical properties of micro-bubbles in the Department of Mechanical Engineering at the Shibaura Institute of Technology under the leadership of Associate Professor, Dr Yoko Yamanishi.
Dr Yoko Yamanishi is an Associate Professor in the Department of Mechanical Engineering at Shibaura Institute of Technology, Tokyo, Japan. She leads the Yamanishi Laboratory - the Micro-nano Functional Fluid Laboratory. The Laboratory's goals aim to clarify unknown function of cells by using micro-nano technology based on mechanical, electrical and bio-medical engineering. It targets a contribution to the development of cellular scale...
Today the world's no. 2 influenza vaccine provider, Seqirus, announced a £22.1m investment for its UK manufacturing site in Liverpool.
The company, which is part of global biotherapeutics leader CSL Limited, is going to develop a new £15.3m manufacturing facility to support the production of influenza vaccines at its Speke site. The announcement came as Seqirus today celebrated the opening of a £6.8m investment in new warehousing facilities at the site. Seqirus was created in November 2015 following CSL's acquisition of the Novartis influenza vaccines...
INTEGRA, in conjunction with DPX Labs LLC, has produced an application note that describes a novel high throughput semi-automated sample method for processing urine samples ready for drugs of abuse analysis by LC-MS/MS.
Using an INTEGRA VIAFLO 96 electronic pipette with DPX mixed mode tips, a single 96-well plate loaded with samples can be extracted and ready for LC-MS/MS analysis in less than ten minutes eliminating the need for a time-consuming evaporation step. Sample preparation is required to remove matrix interferences from urine samples prior to LC-MS/MS analysis. This procedure is typically very time-consuming and is...
Fast Lyophilisation on the Genevac Series 3 HT Evaporator was developed to provide a rapid, high-throughput alternative to freeze drying HPLC purification fractions.
Traditional evaporation methods of removing solvents, such as water and acetonitrile, often results in formation of a gum or oil due to solvent interactions with the dissolved sample. Employing a Series 3 HT Evaporator with LyoSpeed™ Fast Lyophilisation technology is enabling pharma labs to now routinely dry HPLC fraction samples to a powder form, such that the samples can then be accurately weighed, easily sub-sampled and redissolved. While standard evaporation works...
The University of Rochester Medical Center announced it's collaborating with Indivumed, a Germany-based company, to establish a bank of human tissues and tumor samples that are expertly preserved and stored for use in cancer research.
The URMC signed a three-year agreement with Indivumed; financial details were not disclosed. Approximately 15 other research institutions have formed similar partnerships with the company-including Georgetown University's Lombardi Comprehensive Cancer Center in Washington, D.C., the Geisinger Health System in Pennsylvania, and several medical centers in Europe-enabling a worldwide network for researchers to...
June 19-24, 2016 in San Francisco, CA, USA Robert Kennedy, HPLC 2016 Chair
The program will be packed with papers on column and stationary phase technology, interface to mass spectrometry, microfluidic systems, capillary electrophoresis, LCxLC, QA&QC methods, QbD in separations, and application to real world problems. A special emphasis in applications will be on bioanalysis including: pharmaceuticals, antibody-drug conjugates, antibody characterization, biotechnology, proteins and...
A University of Brighton professor has become the first British citizen to join one of America?s leading organisations supporting research into ageing.
Professor Richard Faragher, Professor of Biogerontology and assistant head of the School of Pharmacy and Biomolecular Sciences, has been elected to the board of directors of the American Federation for Aging Research (AFAR). AFAR is a national non-profit organization whose mission is to support and advance healthy ageing through biomedical research. Founded in 1981, AFAR has championed the cause and supported the funding of science in healthier ageing and...
Technical innovations from TUM could help bring cures within reach
The quest to bring immunotherapy into widespread clinical use against cancer and infectious diseases has made great strides in recent years. For example, clinical trials of adoptive T cell therapy are yielding highly promising results. The latest progress is being reported at the Annual Meeting of the American Association for the Advancement of Science (AAAS 2016) by three international leaders in the field: Prof. Dirk Busch of...
Micreos intends to use the secured funds, which run until 2017, for the global development of Staphefekt™ as a pharmaceutical (Rx) product. Micreos develops targeted antibacterial technology as a sustainable alternative to antibiotics for which it is a recognised leader in the field. Gladskin is the world’s first lysin (enzyme) based product registered for human use. It specifically targets S. aureus, including MRSA on intact skin...
Sophia Genetics announces a strategic partnership with Integrated DNA Technologies to accelerate the adoption of next generation sequencing (NGS) in routine clinical diagnostics.
The Sophia DDM™ advanced analytical platform will be paired with IDT’s xGen® hybridization-based target enrichment panels to provide hospitals with excellent analytical performance, unrivalled flexibility for gene panel composition, and high sample throughput. The NGS bundles will be available immediately to more than 120 hospitals currently using the Sophia DDM™ platform. As additional hospitals add this platform to...
Read MoreGenome Editing: a Scientific RevolutionMar 16, 2016
A distinguished panel of experts from four leading bioscience research institutes come together during this year’s Cambridge Science Festival to discuss and respond to public questions about the current and future applications of genome editing – a process by which sections of DNA are removed or replaced.
Human genomes contain natural errors or mutations. Most are relatively harmless and underpin evolution but some cause life-threatening diseases. In a few cases, patients have been treated by conventional gene therapy, where new genes are incorporated using a carrier virus to counteract defective genes. However, so far few patients have been treated by genomic editing. This could all change now that new and much...
The Asynt CondenSyn Air Condenser has been extensively tested by researchers in the renowned Cronin Group within the School of Chemistry at the University of Glasgow, UK.
Having implemented over 10 of these air condensers for use in inorganic and organic syntheses, as well as long term experimental systems, the Cronin Group were able to confirm that they now spend less set-up time and no longer have to worry over water leaking into electronic control and heating systems. In addition using CondenSyn air condensers has reduced clutter in heavily used fumehood spaces, as it eliminates the...
Bibby Scientific Ltd has announced a market-leading three-year warranty on all its Jenway® spectrophotometers, including the latest 73 series of instruments that are used worldwide in education, research and routine quality control laboratories.
The warranty is supported by Bibby’s exemplary local service and support teams across the UK and Europe. Many analytical and quality testing labs are facing increasing workloads amid stringent regulatory requirements across diverse industrial sectors. These labs rely on high quality, reliable and robust analytical instruments with minimal downtime and extremely responsive support services. “Jenway products are internationally...
Thermo Scientific Environmental Chambers use a unique airflow system for advanced temperature control
A new range of 230-volt environmental chambers, designed to provide highly stable environmental conditions, is now available in Europe, Africa, Latin America and the Asia Pacific region. The newly CE-marked range of Thermo Scientific Environmental Chambers provide temperature control above and below ambient for drug stability testing, shelf-life testing, insect studies or controlled storage. There are two models available in...
Kinesis is pleased to announce that they have been awarded the status of Global Distributor for the IDEX Health & Science MarvelX™ range of UHPLC Connection products.
MarvelX UHPLC Connection Systems have been expertly designed for easy routing throughout your instrument, while providing consistent performance and superior re-usability. Built with convenient, removable stainless steel fittings and changeable, precision-cut flexible tubing, MarvelX can be used up to 200 times! MarvelX uses patented technology to automatically adjust to various port depths, with standard 10-32 coned...
New red, blue and black kits for conjugation of antibodies and proteins to latex beads
Innova Biosciences, a specialist provider of bioconjugation products and services, today announced the launch of new red, black and blue 400nm LATEX conjugation kits. Innova Biosciences’ LATEX conjugation kits are one-step kits for the covalent conjugation of antibodies and proteins to specially treated latex beads, for use in the diagnostics field and across other applications. The new conjugation kits are easy to...
Attendance by Edwina Hart, Minister for Economy, Science and Transport for the Welsh Government
Sphere Medical, an innovator company in critical care monitoring and diagnostics equipment, has opened its new commercial production facility in St. Asaph, Wales. Edwina Hart, Minister for Economy, Science and Transport for the Welsh Government, was present to officially open the new manufacturing facility for Sphere’s Proxima patient-dedicated blood gas analyser. The new facilities include a state of the art cleanroom and will provide the necessary manufacturing...
Thermo Scientific MSIA Streptavidin EVO microcolumns simplify large molecule bioanalysis
A new, fully automated affinity purification solution is designed to enable scientists to analyze large biomolecules, such as proteins and antibodies, with improved accuracy, consistency and simplicity, even at high throughputs. The new Thermo Scientific MSIA Strepdavidin EVO microcolumns have been designed to bring the novel mass spectrometric immunoassay (MSIA) affinity purification technology to...
Scientists at BioGenes GmbH, Berlin and Greenovation Biotech GmbH, Freiburg, have cooperated to develop a novel host-cell protein (HCP) assay for Greenovation’s Physcomitrella patens expression system.
The data have been published in the Journal BioProcess International in February 2016 by Dabrowska-Schlepp and colleagues. HCPs are inevitable impurities found in biopharmaceutical products originating from recombinant cell culture. HCPs are a heterogeneous mix of different proteins, and their specific characteristics depend on the kind of organism used as an expression platform. Contamination of a final drug substance with...
Interview released with US Federal Agency, Biomedical Advanced Research and Development Authority (BARDA), in the run up to SMi’s 18th annual show on antimicrobial resistance.
SMi’s 18th annual conference on “Superbugs & Superdrugs” returns to London this March and is thrilled to have Dr. Christopher Houchens, Project Manager of BARDA's Anti-Infective Programme, as one of the keynote speakers for 2016. It was announced last September that the US Government would provide the federal agency, BARDA, which works on national preparedness for chemical and biological threats, funding of $96 million to explore new therapies
Jason Mundin has joined the board as Commercial Director to drive the growth of Ubiquigent along with Jason Brown, founder and now Scientific Director and Mark Treherne, Executive Chairman. Laurence Ede also joins as a non-executive director to support the development of the company. John Harris has joined the Scientific Advisory Board to lead Ubiquigent’s new chemistry strategy. Ubiquigent also announced the...
Dr Yoko Yamanishi is an Associate Professor in the Department of Mechanical Engineering at Shibaura Institute of Technology, Tokyo, Japan. She leads the Yamanishi Laboratory - the Micro-nano Functional Fluid Laboratory. The Laboratory's goals aim to clarify unknown function of cells by using micro-nano technology based on mechanical, electrical and bio-medical engineering. It targets a contribution to the development of cellular scale...
The company, which is part of global biotherapeutics leader CSL Limited, is going to develop a new £15.3m manufacturing facility to support the production of influenza vaccines at its Speke site. The announcement came as Seqirus today celebrated the opening of a £6.8m investment in new warehousing facilities at the site. Seqirus was created in November 2015 following CSL's acquisition of the Novartis influenza vaccines...
Using an INTEGRA VIAFLO 96 electronic pipette with DPX mixed mode tips, a single 96-well plate loaded with samples can be extracted and ready for LC-MS/MS analysis in less than ten minutes eliminating the need for a time-consuming evaporation step. Sample preparation is required to remove matrix interferences from urine samples prior to LC-MS/MS analysis. This procedure is typically very time-consuming and is...
Traditional evaporation methods of removing solvents, such as water and acetonitrile, often results in formation of a gum or oil due to solvent interactions with the dissolved sample. Employing a Series 3 HT Evaporator with LyoSpeed™ Fast Lyophilisation technology is enabling pharma labs to now routinely dry HPLC fraction samples to a powder form, such that the samples can then be accurately weighed, easily sub-sampled and redissolved. 
The URMC signed a three-year agreement with Indivumed; financial details were not disclosed. Approximately 15 other research institutions have formed similar partnerships with the company-including Georgetown University's Lombardi Comprehensive Cancer Center in Washington, D.C., the Geisinger Health System in Pennsylvania, and several medical centers in Europe-enabling a worldwide network for researchers to...
The program will be packed with papers on column and stationary phase technology, interface to mass spectrometry, microfluidic systems, capillary electrophoresis, LCxLC, QA&QC methods, QbD in separations, and application to real world problems. A special emphasis in applications will be on bioanalysis including: pharmaceuticals, antibody-drug conjugates, antibody characterization, biotechnology, proteins and...
Professor Richard Faragher, Professor of Biogerontology and assistant head of the School of Pharmacy and Biomolecular Sciences, has been elected to the board of directors of the American Federation for Aging Research (AFAR). 
The quest to bring immunotherapy into widespread clinical use against cancer and infectious diseases has made great strides in recent years. For example, clinical trials of adoptive T cell therapy are yielding highly promising results. The latest progress is being reported at the Annual Meeting of the American Association for the Advancement of Science (AAAS 2016) by three international leaders in the field: Prof. Dirk Busch of...
Micreos intends to use the secured funds, which run until 2017, for the global development of Staphefekt™ as a pharmaceutical (Rx) product. Micreos develops targeted antibacterial technology as a sustainable alternative to antibiotics for which it is a recognised leader in the field. Gladskin is the world’s first lysin (enzyme) based product registered for human use. It specifically targets S. aureus, including MRSA on intact skin...
The Sophia DDM™ advanced analytical platform will be paired with IDT’s xGen® hybridization-based target enrichment panels to provide hospitals with excellent analytical performance, unrivalled flexibility for gene panel composition, and high sample throughput. The NGS bundles will be available immediately to more than 120 hospitals currently using the Sophia DDM™ platform. As additional hospitals add this platform to...
Human genomes contain natural errors or mutations. Most are relatively harmless and underpin evolution but some cause life-threatening diseases. In a few cases, patients have been treated by conventional gene therapy, where new genes are incorporated using a carrier virus to counteract defective genes. However, so far few patients have been treated by genomic editing. This could all change now that new and much...
Having implemented over 10 of these air condensers for use in inorganic and organic syntheses, as well as long term experimental systems, the Cronin Group were able to confirm that they now spend less set-up time and no longer have to worry over water leaking into electronic control and heating systems. In addition using CondenSyn air condensers has reduced clutter in heavily used fumehood spaces, as it eliminates the...
The warranty is supported by Bibby’s exemplary local service and support teams across the UK and Europe. Many analytical and quality testing labs are facing increasing workloads amid stringent regulatory requirements across diverse industrial sectors. These labs rely on high quality, reliable and robust analytical instruments with minimal downtime and extremely responsive support services. “Jenway products are internationally...
A new range of 230-volt environmental chambers, designed to provide highly stable environmental conditions, is now available in Europe, Africa, Latin America and the Asia Pacific region. The newly CE-marked range of Thermo Scientific Environmental Chambers provide temperature control above and below ambient for drug stability testing, shelf-life testing, insect studies or controlled storage. There are two models available in...
MarvelX UHPLC Connection Systems have been expertly designed for easy routing throughout your instrument, while providing consistent performance and superior re-usability. Built with convenient, removable stainless steel fittings and changeable, precision-cut flexible tubing, MarvelX can be used up to 200 times! MarvelX uses patented technology to automatically adjust to various port depths, with standard 10-32 coned...
Innova Biosciences, a specialist provider of bioconjugation products and services, today announced the launch of new red, black and blue 400nm LATEX conjugation kits. Innova Biosciences’ LATEX conjugation kits are one-step kits for the covalent conjugation of antibodies and proteins to specially treated latex beads, for use in the diagnostics field and across other applications. The new conjugation kits are easy to...
Sphere Medical, an innovator company in critical care monitoring and diagnostics equipment, has opened its new commercial production facility in St. Asaph, Wales. Edwina Hart, Minister for Economy, Science and Transport for the Welsh Government, was present to officially open the new manufacturing facility for Sphere’s Proxima patient-dedicated blood gas analyser. The new facilities include a state of the art cleanroom and will provide the necessary manufacturing...
The data have been published in the Journal BioProcess International in February 2016 by Dabrowska-Schlepp and colleagues. HCPs are inevitable impurities found in biopharmaceutical products originating from recombinant cell culture. HCPs are a heterogeneous mix of different proteins, and their specific characteristics depend on the kind of organism used as an expression platform. Contamination of a final drug substance with...
Introducing New Exosome Products from Biovision!